SCHEMBL13545756

SCHEMBL13545756

Cc1ccccc1CNC(=O)c1n[nH]c2c1CC(C)CC2

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ RIPK1 Q13546 5/20 0.50
▸ NPC1 O15118 2/20 0.44
▸ RAB9A P51151 1/20 0.44
▸ ALDH1A1 P00352 3/20 0.44
▸ HPGD P15428 2/20 0.44
▸ HCAR2 Q8TDS4 1/20 0.44
▸ AURKA O14965 1/20 0.44
▸ ITK Q08881 1/20 0.44
▸ CDK5 Q00535 1/20 0.42
▸ CDK5R1 Q15078 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ GAA P10253 2/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ HTT P42858 1/20 0.42
▸ P2RX7 Q99572 1/20 0.42
▸ ADORA2A P29274 1/20 0.41
▸ ADORA1 P30542 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3580404 0.84 NPC1 (0.52) NPC1RAB9AALDH1A1HPGDHCAR2
SCHEMBL13545791 0.79 RIPK1 (0.47) RIPK1NPC1RAB9AALDH1A1HCAR2
SCHEMBL13545769 0.79 SMN1; SMN2 (0.68) RIPK1NPC1RAB9AALDH1A1HPGD
SCHEMBL13545778 0.79 RIPK1 (0.50) RIPK1NPC1RAB9AALDH1A1HPGD
SCHEMBL20441015 0.74 RIPK1 (0.49) RIPK1NPC1RAB9AAURKAITK
SCHEMBL18372860 0.71 HCAR2 (0.47) RIPK1NPC1RAB9AHCAR2CDK5
SCHEMBL8282611 0.71 HCAR2 (0.61) HCAR2
SCHEMBL13545861 0.71 HPGD (0.50) ALDH1A1HPGDKDM4EHTTP2RX7
SCHEMBL18366182 0.69 KDM4E (0.45) RIPK1NPC1RAB9AALDH1A1HPGD
SCHEMBL13545806 0.67 HTT (0.45) RIPK1NPC1RAB9AALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100022530-A1 TETRAHYDROBENZOISOXAZOLE AND TETRAHYDROINDAZOLE DERIVATIVES AS MODULATORS OF THE MITOTIC MOTOR PROTEIN MERCK PATENT GMBH (DE) 2010-01-28 — — US disclosed
US-20100022530-A1 TETRAHYDROBENZOISOXAZOLE AND TETRAHYDROINDAZOLE DERIVATIVES AS MODULATORS OF THE MITOTIC MOTOR PROTEIN MERCK PATENT GMBH (DE) 2010-01-28 — — US disclosed
WO-2008080455-A1 TETRAHYDROBENZOISOXAZOLE - AND TETRAHYDROINDAZOLE DERIVATIVES AS MODULATORS OF THE MITOTIC MOTOR PROTEIN MERCK PATENT GMBH (DE) 2008-07-10 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100022530-A1 TETRAHYDROBENZOISOXAZOLE AND TETRAHYDROINDAZOLE DERIVATIVES AS MODULATORS OF THE MITOTIC MOTOR PROTEIN CCNB3, TUBB3, CCNB1 RIPK1 3431/4885NPC1 4626/4885RAB9A 1951/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback